What clinical studies were done for Humalog (insulin lispro)?
Humalog is an insulin analog used to improve blood glucose control in people with diabetes. Clinical studies for insulin lispro have included both people with type 1 diabetes and people with type 2 diabetes, typically comparing how well it controls glucose versus regular human insulin, using measures such as HbA1c and glucose outcomes during meals.
How does Humalog work in clinical trials during meals?
Insulin lispro is designed to act faster than regular human insulin, which is why many clinical protocols test it around mealtimes (for example, dosing shortly before eating). Trials commonly evaluate whether this faster onset improves post-meal (postprandial) glucose control compared with older insulin regimens.
What outcomes do Humalog studies measure?
Across insulin lispro trials, the most common clinical endpoints include:
- HbA1c changes over weeks to months
- Blood glucose levels around meals (postprandial glucose)
- Hypoglycemia rates (including severe or confirmed episodes)
- Safety and tolerability outcomes
Are there studies in special populations (children, pregnancy, older adults)?
Insulin lispro has been studied in multiple patient groups beyond adults, including pediatric populations and people who are pregnant (where dosing and glucose monitoring requirements can differ). Trial designs often adjust timing of injections and monitoring schedules to match the needs of each group.
Where can I find official Humalog trial results?
For detailed, study-level information (protocol IDs, inclusion criteria, outcomes, and results), the best starting points are clinical trial registries and regulatory reviews. If you want, tell me whether you mean:
- the original Humalog development studies (insulin lispro vs regular human insulin), or
- newer Humalog formulations and delivery systems,
and I can narrow it to the most relevant study records.
How do I look up a specific Humalog study by design or year?
If you share one of the following, I can help pinpoint the right study:
- patient type (type 1 vs type 2 vs gestational vs pediatric)
- comparison (vs regular insulin, vs other rapid-acting insulins)
- timeframe (year or decade)
- whether you mean Humalog or another product name (e.g., a specific insulin lispro formulation)
Sources
No specific Humalog clinical study documents were provided in the prompt, so I can’t cite particular trial results or registry entries yet.